Cancer Care Coordination for Chemotherapy Patients
4CP
Use of mHealth to Support Nurse-directed Care Coordination for Chemotherapy Patients: Improving Health, Healthcare Delivery, and Healthcare Utilization.
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of this study is to compare nurse-led care coordination for persons receiving cancer chemotherapy treatment incorporating mobile health technology to nurse-led care coordination without any mobile health enhancements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started Dec 2013
Longer than P75 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 10, 2014
CompletedFirst Posted
Study publicly available on registry
September 12, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2017
CompletedNovember 16, 2018
November 1, 2018
3.8 years
September 10, 2014
November 15, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Patient Health Outcome
Pain
Baseline, 3 months, 6 months
Secondary Outcomes (1)
Demonstration of a HIPAA-compliant platform to coordinate care overtime
Baseline, 6 months
Other Outcomes (4)
Change in Patient Health Outcomes
Baseline, 3 months, 6 months
Change in Healthcare Outcomes
Baseline, 6 months
Change in Healthcare Utilization
Baseline, 3 months, 6 months
- +1 more other outcomes
Study Arms (2)
Mobile Health (mHealth)
EXPERIMENTALCare coordination using mHealth technology enhancements
No mHealth
ACTIVE COMPARATORCare coordination without mHealth enhancements
Interventions
Participants receive care coordination throughout their chemotherapy treatment using mHealth technology
Participants receive the same evidence-based care coordination without mHealth technology
Eligibility Criteria
You may qualify if:
- years or older
- Newly diagnosed cancer - any site or stage
- Initiating chemotherapy
- Ability to read and write English
- Manual dexterity sufficient to use a tablet technology
- Cognitive capacity to participate
- Preferential recruitment of publicly insured and/or living in rural communities
You may not qualify if:
- Oral chemotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, Davislead
- McKesson Foundationcollaborator
- Boston Universitycollaborator
Study Sites (1)
UC Davis Comprehensive Cancer Care Center
Sacramento, California, 95817, United States
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jill G Joseph, MD, PhD
University of California, Davis Betty Irene Moore School of Nursing
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 10, 2014
First Posted
September 12, 2014
Study Start
December 1, 2013
Primary Completion
October 1, 2017
Study Completion
October 1, 2017
Last Updated
November 16, 2018
Record last verified: 2018-11